- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
eyeforpharma Awards 2019 Announced
eyeforpharma announced the date for their awards event for 2019. The eyeforpharma awards focus exclusively on value for patients and HCPs to support the best work in the industry.
The awards will be celebrating health entrepreneurs, valuable collaborations, patient advocates, and champions. The patient awards will be judged by a group of patients for the patients. The nominations are now open for the 13 categories, and the ceremony will take place on December 11th in Philadelphia.
Nominations open 29th April, closing 9th August, with Finalists announced by eyeforpharma on 5th September. Finalists will be selected by a judging panel of industry experts.
For more information, visit here or contact Liz Swift at eswift@eyeforpharma.com.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
